收藏切换
Research progress on clinical efficacy and pharmacological mechanism of salvianolate in treating coronary atherosclerotic heart disease
收藏切换
Huimin BAI, Can FENG, Feng WU, Min FAN*
World Clinical Drug | 2024, 45(4) : 424 - 429
Less
收藏切换
World Clinical Drug | 2024, 45(4): 424-429
• Review •
Research progress on clinical efficacy and pharmacological mechanism of salvianolate in treating coronary atherosclerotic heart disease
Full
Huimin BAI, Can FENG, Feng WU, Min FAN*
Affiliations
  • Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
Published: 2024-04-10 doi: 10.13683/j.wph.2024.04.014
Outline
收藏切换

Coronary atherosclerotic heart disease (CAHD) can be clinically classified as stable angina pectoris (SAP), unstable angina pectoris (UAP), and myocardial infarction (MI), the pathogenesis of which includes endothelial damage, inflammation, oxidative stress, plaque rupture, and thrombosis. Western medicine, percutaneous coronary intervention and coronary artery bypass grafting are effective in the prevention and treatment of CAHD, but the incidence of cardiovascular adverse events is still high. Salvia miltiorrhiza can inhibit inflammation, reduce myocardial ischemic injury, inhibit platelet aggregation and activation, improve MI area, etc. It is one of the most commonly used Chinese medicines in the treatment of chest arthralgia and heartache, and is also a common drug in the treatment of CAHD. This paper reviewed the clinical efficacy and pharmacological mechanism of salvianolate for CAHD, based on the pathogenesis of SAP, UAP and MI, in order to provide reference for clinical practice.

salvianolate  /  coronary atherosclerotic heart disease  /  clinical efficacy  /  pharmacological mechanism
白惠敏, 冯灿, 伍锋, 樊民. 丹参多酚酸盐对冠状动脉粥样硬化性心脏病的临床疗效和药理机制研究进展. 世界临床药物, 2024 , 45 (4) : 424 -429 . DOI: 10.13683/j.wph.2024.04.014
Huimin BAI, Can FENG, Feng WU, Min FAN. Research progress on clinical efficacy and pharmacological mechanism of salvianolate in treating coronary atherosclerotic heart disease[J]. World Clinical Drug, 2024 , 45 (4) : 424 -429 . DOI: 10.13683/j.wph.2024.04.014
Year 2024 volume 45 Issue 4
18
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.04.014
  • Receive Date:2023-06-18
  • Online Date:2026-11-17
  • Published:2024-04-10
Article Data
Affiliations
History
  • Received:2023-06-18
  • Revised:2023-12-12
Funding
Affiliations
    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.04.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT